Symyx Technologies — Merger or Acquisition (April 2010)
15 slides from Symyx Technologies's merger presentation, Apr 5, 2010
Slide 1: Filed by Accelrys, Inc. Pursuant to Rule 425
Filed by Accelrys, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 (the “Exchange Act”) Subject Company: Symyx Technologies, Inc. Exchange Act File Number: 000-27765 This filing relates to the proposed merg
Slide 2: Accelrys & Symyx Investor Presentation
Accelrys & Symyx Investor Presentation
Slide 3: Safe Harbor Information
Safe Harbor Information Non-historical statements in this presentation are forward- looking statements under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks, uncertainties and assumptions, in
Slide 4: Accelrys and Symyx to Merge
Accelrys and Symyx to Merge Accelrys and Symyx Agree to Merge • Companies have entered into definitive merger agreement • Transaction expected to complete by end of June 2010 subject to shareholder approval Merger Outcome • Creates the leading enterprise scientific informatics software system compan
Slide 5: Combining Industry Leaders
Combining Industry Leaders Founded:2001 Founded:1996 Public:ACCL(NASDAQ) Public:SMMX(NASDAQ) FY2009Revenue:$80.9M CY2009Revenue:$88.6M* Leading positions in: Leading positions in: Data Collection and Analysis Electronic Laboratory Notebook Data Access, Integration & Transformation Decision Support,
Slide 6: Scientific R&D Challenges
Scientific R&D Challenges Balance Innovation, Automation, Collaboration The economics of innovation - as R&D is done today – are unsustainable. If companies are to overcome these obstacles they will need to establish processes and structures that promote innovation… The Enterprise of the Future IBM
Slide 7: Combined Company Addresses Required Needs
Combined Company Addresses Required Needs Unequaled capabilities in scientific software and services Deep domain expertise in chemistry, biology and materials science Ability to improve scientific R&D processes and their outcomes Unique, open, enterprise scale informatics system for global scientifi
Slide 8: Combined Company Solution
Combined Company Solution Offering Enables Customer Benefit Creation, capture, execution and reuse Improves scientist productivity by working more Electronic Lab Notebook of scientific processes, data and experiments efficiently and collaboratively Decision Support Deep analysis of complex Derivatio
Slide 9: Leading in Scientific R&D Workflows in Growing Markets
Leading in Scientific R&D Workflows in Growing Markets Store, Search and Manage Diverse Scientific Data Create, Execute and Scientific Informatics and Intellectual Property Reuse Scientific Experiments Software System Electronic Lab Notebook Decision Support And Analytics Reporting, Visualization An
Slide 10: With Global Brand Customer Portfolio and Minimal Product Overlap
With Global Brand Customer Portfolio and Minimal Product Overlap Accelrys + Symyx has over 1,350 total, unique customers including • 29 of the top 30 biopharmaceutical companies • 5 of the top 5 chemical companies • 5 of the top 5 aerospace companies • 3 of the top 5 CPG companies • And major Govern
Slide 11: Vibrant & Growing Partner Ecosystem
Vibrant & Growing Partner Ecosystem Additional applications and solutions developed by partner community More choice for customers in implementing successful deployments Scientific Informatics Software System Electronic Lab Notebook Decision Support And Analytics Reporting, Visualization And Collabo
Slide 12: Terms of Deal
Terms of Deal Merger Agreement Tax-free, all stock merger of equals Closing Expected to close end of June 2010 Exchange Ratio 0.7802 Ownership Each company’s stockholders will own approximately 50% of combined company Market Capitalization Combined market cap of ~ $335M (pre-announcement) Cash Posit
Slide 13: Pro Forma Combined CY 2009 Financial Metrics
Pro Forma Combined CY 2009 Financial Metrics Pro Forma Metric(1) Accelrys Symyx Combined(2) CY2009 Revenue $82.2 $88.6 $170.8 CY2009 EBIT $6.0 $11.0 $17.0 CY2009 EBITDA (5) $7.8 $14.0 $21.8 Net Cash (3) $72.0 $81.8 $153.8 Market Capitalization (4) $179.8 $155.1 $334.9 (1) Source: Historical financia
Slide 14: Accelrys & Symyx
G accelrys Symyx Accelrys & Symyx
Slide 15: Forward-Looking Statements
Forward-Looking Statements Certain statements in this communication may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to a variety of matters, including but not limited to: the timing and anticipated complet
Symyx Technologies — Merger or Acquisition (April 2010) on 6ix